Familial hypercholesterolaemia trials in United States
40 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleA Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
- Where
- Atlanta, Boca Raton, Boston, Cincinnati, Morgantown, St Louis, Washington D.C., Wilmington
- Age
- 6 years to 17 years
- People
- 153 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07058077 · EU 2024-519068-42-00 - Phase 2Taking peopleA Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular Disease
- Where
- DeSoto
- Age
- 18 years to 70 years
- People
- 175
- Run by
- Verve Therapeutics, Inc.
See details and how to joinNCT07839936 · EU 2026-525691-26-00 - No phaseTaking peopleCauses and Natural History of Dyslipidemias
- Where
- Bethesda
- Age
- 2 years to 100 years
- People
- 2,000
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT00353782 - No phaseNot yet taking people in United StatesPenn Family Screening for Familial Hypercholesterolemia (NHLBI R33) Trial 3
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 110
- Run by
- Northwestern University
See details and how to joinNCT07919353 - No phaseTaking peoplePharmacogenomic Informed Statin Prescribing
- Where
- Durham, Indianapolis
- Age
- 40 years to 75 years
- People
- 214
- Run by
- VA Office of Research and Development
See details and how to joinNCT06568601 - Phase 4Taking peopleInclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Where
- Albany, Albuquerque, Alexander City, Amarillo, Anderson, Asheville, Aurora, Austin, Avondale, Bangor, Bethlehem, Beverly Hills, Birmingham, Bossier City, Bridgeport, Bridgewater, Buffalo, Camp Hill, Canton, Chambersburg, Charlotte, Chicago, Chula Vista, Clearwater, Clinton, Columbia, Concord, Conroe, Coral Gables, Covina, Covington, Danbury, Daytona Beach, Duluth, Elkhart, Elmer, Englewood, Fayetteville, Flemington, Gainesville, Germantown, Glendora, Grand Island, Green Bay, Greeneville, Greensboro, Haddon Heights, High Point, Houston, Humble, Huntsville, Jackson, Jacksonville, Jonesboro, Kingwood, Lancaster, Lanham, Lansing, Largo, Lebanon, Lincoln, Little Rock, Lufkin, Mankato, McAllen, Merrillville, Miami Lakes, Midland, Milwaukee, Morrisville, Murray, Nashville, New Orleans, Newport Beach, Newport News, New York, Norfolk, Northridge, Oklahoma City, Omaha, Overland Park, Owensboro, Panama City, Park Ridge, Peachtree City, Peoria, Pomona, Pontiac, Port Charlotte, Poughkeepsie, Puyallup, Raleigh, Rapid City, Richmond, Riverside, Rochester, Rochester Hills, Rockford, Rockville, Round Rock, Safety Harbor, Salisbury, San Diego, San Francisco, San Marcos, Sewell, Shreveport, Silver Spring, Southaven, Springfield, Stamford, Staten Island, Tacoma, Takoma Park, Tampa, The Bronx, Thornton, Toledo, Tomball, Torrance, Tucker, Tupelo, Van Nuys, Ventura, West Des Moines, West Hills, West Monroe, West Reading, Wichita, Winchester, Winston-Salem, York, Zanesville
- Age
- 18 years and over
- People
- 6,000
- Run by
- Duke University
See details and how to joinNCT06909565 - Phase 3Taking peopleStudy of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia
- Where
- St Louis
- Age
- 12 years to 17 years
- People
- 10 worldwide
- Run by
- Arrowhead Pharmaceuticals
See details and how to joinNCT07473843 · EU 2025-523662-24-00 - Phase 1Taking peoplePhase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
- Where
- Clearwater, Garden Grove, Miami Lakes, New York, Port Orange
- Age
- 18 years to 70 years
- People
- 132 worldwide
- Run by
- Verve Therapeutics, Inc.
See details and how to joinNCT06451770 · EU 2025-522617-39-00 - No phaseTaking peopleTest 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?
- Where
- Minneapolis
- Age
- 18 years and over
- People
- 400
- Run by
- Duke University
See details and how to joinNCT06471036 - No phaseTaking peopleThe ORIGIN-FH Study
- Where
- Madison
- Age
- 18 years and over
- People
- 70
- Run by
- University of Wisconsin, Madison
See details and how to joinNCT07470723 - No phaseTaking peopleComputerized Decision Support for Identification and Management of Familial Hypercholesterolemia
- Where
- Boston
- People
- 450
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT06743659 - Phase 3Taking peopleLong-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
- Where
- Boca Raton, Cincinnati, New York, Pittsburgh, Salt Lake City
- Age
- 2 years to 100 years
- People
- 195 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05682378 - Phase 1Taking peopleA Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
- Where
- Durham, Hialeah, High Point, Jacksonville, Orlando, Portland, Port Orange, Rochester
- Age
- 18 years to 75 years
- People
- 90 worldwide
- Run by
- CRISPR Therapeutics AG
See details and how to joinNCT07491172 - No phaseNot yet taking people in United StatesCascade Testing In Identifying At-risk Family Members Of Individuals With Familial Hypercholesterolemia (FH) In PCP
- Where
- Rochester
- Age
- 1 year and over
- People
- 480
- Run by
- Mayo Clinic
See details and how to joinNCT07653555 - Phase 1Taking peopleA Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
- Where
- Boca Raton, DeSoto, Dothan, High Point, Indianapolis, Jacksonville, Philadelphia, Pomona, Renton, Winter Park
- Age
- 18 years to 70 years
- People
- 85 worldwide
- Run by
- Verve Therapeutics, Inc.
See details and how to joinNCT06164730 - Phase 2Taking people2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)
- Where
- Nashville
- Age
- 18 years to 69 years
- People
- 72
- Run by
- Vanderbilt University Medical Center
See details and how to joinNCT04941599 - Phase 2Taking peopleA Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Where
- Boca Raton, Brandon, Canton, Chicago, Cooper City, Coral Gables, Doral, Foley, Ft. Washington, Houston, Jacksonville, Lanham, Lincoln, Little River, Los Angeles, Manassas, Miami, Miami Lakes, Monroe, Niles, Northridge, Pembroke Pines, Richmond, Saint Augustine, Saraland, West Monroe, Wichita
- Age
- 18 years to 75 years
- People
- 120
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07610278 - Phase 3Enrolling by invitationStudy to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH
- Where
- Cincinnati
- Age
- 6 years to 17 years
- People
- 150 worldwide
- Run by
- LIB Therapeutics LLC
See details and how to joinNCT07102511 · EU 2025-524214-28-00 - Phase 3Taking peopleStudy to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Where
- Salt Lake City, San Francisco, St Louis, Washington D.C.
- Age
- 2 years to 11 years
- People
- 9 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597006 - No phaseTaking peoplePilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food
- Where
- Sommerville
- Age
- 18 years to 60 years
- People
- 20
- Run by
- Cambridge Health Alliance
See details and how to joinNCT06988462 - No phaseEnrolling by invitationAdvancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors
- Where
- New Brunswick
- Age
- 18 years and over
- People
- 266
- Run by
- Rutgers, The State University of New Jersey
See details and how to joinNCT06834204 - No phaseEnrolling by invitationImproving Lipid Optimization Quality and Treatment Options in ASCVD
- Where
- Boston
- Age
- 18 years to 95 years
- People
- 300
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT06960655 - Phase 2Not yet taking people in United StatesUse of Bile Acid Binding Resins to Decrease PFAS Levels Via Colesevalem in Veterans Study
- Where
- Augusta, Louisville
- Age
- 25 years to 65 years
- People
- 50
- Run by
- University of Rhode Island
See details and how to joinNCT07592858 - Phase 3Taking peopleStudy to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- Where
- Boca Raton, Morgantown, New York, Richmond, Salt Lake City, San Francisco, Washington D.C.
- Age
- 6 years to 11 years
- People
- 60 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597019 - No phaseEnrolling by invitationVirtual Lifestyle Intervention for Weight Management and Cardiovascular Heal
- Where
- San Francisco
- Age
- 30 years to 60 years
- People
- 200
- Run by
- Truemedicine Inc
See details and how to joinNCT07572721